What “Negotiating” With Medicare Means For Drug Makers: A Mixture Of Price Controls And Actual Negotiations Forbes, 01 Sep 2022 am EDT|New! Click on the conversation bubble to join the conversation Got it! In the debate on the drug pricing provisions…